51. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing
- Author
-
Yinghong Zhu, Lagabaiyila Zha, Yingkang Li, Chuan Huang, Guangxiu Lu, Qiaohui Yang, Qi Ouyang, Yingying Peng, Mingyue Kong, Ge Lin, and Di Zhou
- Subjects
Male ,0301 basic medicine ,Heterozygote ,Tumor suppressor gene ,DNA repair ,Human Embryonic Stem Cells ,Cell Culture Techniques ,Biology ,medicine.disease_cause ,Cell Line ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,CRISPR ,lcsh:QH301-705.5 ,Gene Editing ,Mutation ,Base Sequence ,Cas9 ,Cell Biology ,General Medicine ,Embryonic stem cell ,Cell biology ,030104 developmental biology ,lcsh:Biology (General) ,Cell culture ,CRISPR-Cas Systems ,Tumor Suppressor Protein p53 ,030217 neurology & neurosurgery ,Developmental Biology ,Human embryonic stem cell line - Abstract
p53 is a tumor suppressor gene involved mainly in the regulation of the G1/S cell cycle phase, DNA repair, and senescence. Although p53 is frequently altered in human cancer, the consequences of its depletion in human embryonic stem cells (hESCs) are unknown. We generated NERCe003-A-3, a p53 knockout hESC line, from the normal NERCe003-A hESC line by using CRISPR/Cas9 editing. This cell line maintained a normal 46, XY karyotype. Further analysis suggested that the cells expressed pluripotency-related markers and had the capacity to differentiate in vitro into derivatives of all three germ layers.
- Published
- 2019